Why the study?
Imaging phenotypes resembling left ventricular non-compaction occur in athletes, pregnancy, and hemoglobinopathies, requiring clinical distinction between a reversible physiological adaptation and a structural cardiomyopathy.
Does left ventricular non-compaction (LVNC)-like morphology in elite athletes, pregnant women, and patients with hemoglobinopathies reflect a reversible physiological adaptation or a structural cardiomyopathy associated with ventricular dysfunction and adverse clinical events?
Systematic Review
Does left ventricular non-compaction (LVNC)-like morphology in elite athletes, pregnant women, and patients with hemoglobinopathies reflect a reversible physiological adaptation or a structural cardiomyopathy associated with ventricular dysfunction and adverse clinical events?
Isolated LVNC-like trabecular morphology occurs in athletes, pregnancy, and hemoglobinopathies without inevitable cardiomyopathy, but longitudinal reversibility is only demonstrated in pregnancy, underscoring the need for comprehensive clinical and functional context rather than relying on imaging ratios alone.
Requires functional and clinical correlation beyond imaging criteria in these groups; leaves open long-term prognostic implications.
Background: Left ventricular non-compaction (LVNC) describes an imaging phenotype with prominent trabeculations and a thin compacted myocardial layer. Similar appearances occur in athletes, pregnancy, and hemoglobinopathies. Their clinical interpretation requires distinction between isolated morphology and cardiomyopathy. Methods: A systematic review with narrative synthesis examined nine observational imaging reports. Imaging frequency, ventricular function, serial trabecular change and clinical events were distinguished. During revision, all nine full texts underwent design-specific JBI reassessment. Heterogeneous definitions precluded pooling. Results: Gati and Dorobantu reported fulfillment of imaging criteria in 8.1% and 6.5% of athletes; Caselli reported prominent trabeculation in 1.4%. Di Gioia reported isolated trabeculations in 435/1,492 athletes (29.1%); follow-up was available in 61.3%, limiting prognostic inference. In 102 pregnant women, 26 developed trabeculations and eight met both echocardiographic criteria. Postpartum regression was observed, although participant-flow discrepancies limit final proportions. In sickle cell disease, increased trabeculation occurred in 28/99 patients; 8.1% met both criteria. Likely overlapping thalassemia reports described frequencies of 13.3% and 7.9%, with stability reported over 5.1 years in the latter. Conclusions: Isolated LVNC-like morphology can occur without clinically evident cardiomyopathy in these populations. Pregnancy provides limited longitudinal evidence of reversibility; reversibility in athletes and hemoglobinopathies is not demonstrated by the nine analyzed reports. Preserved function and reported event-free follow-up support contextual assessment but do not establish absence of long-term risk.
No takes yet. Share an insight, caveat, or question.
Romero et al. (2026) conducted a systematic review in Left ventricular non-compaction (LVNC) / hypertrabeculation. Physiologic/high-output states (endurance/competitive training, pregnancy, chronic anemia/hemoglobinopathies) vs. Healthy/sedentary controls or individuals without LVNC-like morphology was evaluated on Clinical outcomes (all-cause mortality, heart failure events/hospitalizations, clinically relevant arrhythmias, thromboembolic events), reversibility or stability of trabeculations over time, and global ventricular function (LVEF).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: